Dr. Geneviève Bernard is among the recipients of D2R funding to support her groundbreaking research on RNA-based therapies for cancer and rare genetic diseases

Loydie Jerome-Majewska, PhD, a Senior Scientist in the CHHD Program, co-leads $8.3 million genomics sequencing project to advance healthcare for Black communities

New funding from Génome Québec will strengthen rare disease data infrastructure, accelerating research and discoveries.
Since its launch in early 2024, RARE.Qc has grown to include almost 150 researchers, clinicians, patient advocates, and students, with 25 scientists from The Institute actively contributing to groundbreaking studies. At the heart of this initiative, along with Dr. Vinh, are three co-directors: Geneviève Bernard, MD, Scientist in the Child Health and Human Development (CHHD) Program at The Institute, Dr. Philippe Campeau, from the Centre Hospitalier Universitaire Sainte-Justine, and Nicolas Pilon from the Université du Québec à Montréal.